NMRA vs TOST · $283.5M cap vs P/E 161, rev $4.96B
Neumora Therapeutics, Inc. (NMRA) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Toast Inc (TOST) is a software - infrastructure company listed on US.
NMRA does not have a complete income-statement cache yet.
Latest reported TOST revenue for 2024-12-31 was $4.96B. Net income was $19.0M. Revenue was up 28.3% from 2023-12-31 to 2024-12-31. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
NMRA currently screens at market cap $283.5M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the NMRA and TOST stock pages for the full models.
Not investment advice.